Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (13 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (20)
COVID-19 (3)
Type
(
2 selected
)
Type
Guidance (1649)
Quality standard (0)
Guidance programme
(
11 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 51 to 100 of 1649
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Interventional procedures guidance
Remove Guidance programme: Interventional procedures guidance filter
Guidance programme: Social care guidelines
Remove Guidance programme: Social care guidelines filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Public health guidelines
Remove Guidance programme: Public health guidelines filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Antimicrobial prescribing guidelines
Remove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Cancer service guidelines
Remove Guidance programme: Cancer service guidelines filter
Guidance programme: Medicines practice guidelines
Remove Guidance programme: Medicines practice guidelines filter
Guidance programme: Safe staffing guidelines
Remove Guidance programme: Safe staffing guidelines filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
TA948
31 January 2024
31 January 2024
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)
TA945
30 January 2024
30 January 2024
Devices for remote monitoring of Parkinson's disease
DG51
25 January 2023
25 January 2024
Pharyngeal electrical stimulation for neurogenic dysphagia
IPG781
23 January 2024
23 January 2024
Temperature control to improve neurological outcomes after cardiac arrest
IPG782
23 January 2024
23 January 2024
Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
TA946
17 January 2024
17 January 2024
Sebelipase alfa for treating Wolman disease
HST30
10 January 2024
10 January 2024
Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer
TA944
10 January 2024
10 January 2024
Intravascular lithotripsy for calcified arteries in peripheral arterial disease
IPG780
3 January 2024
3 January 2024
Targeted-release budesonide for treating primary IgA nephropathy
TA937
20 December 2023
20 December 2023
Ravulizumab for treating generalised myasthenia gravis (terminated appraisal)
TA940
20 December 2023
20 December 2023
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)
TA941
20 December 2023
20 December 2023
Empagliflozin for treating chronic kidney disease
TA942
20 December 2023
20 December 2023
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
TA943
19 December 2023
19 December 2023
Risdiplam for treating spinal muscular atrophy
TA755
16 December 2021
15 December 2023
Middle meningeal artery embolisation for chronic subdural haematomas
IPG779
14 December 2023
14 December 2023
Velmanase alfa for treating alpha-mannosidosis
HST29
13 December 2023
13 December 2023
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer
TA939
13 December 2023
13 December 2023
Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal)
TA938
7 December 2023
7 December 2023
Secukinumab for treating moderate to severe hidradenitis suppurativa
TA935
6 December 2023
6 December 2023
Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments (terminated appraisal)
TA936
30 November 2023
30 November 2023
Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism
IPG778
29 November 2023
29 November 2023
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal)
TA933
29 November 2023
29 November 2023
Foslevodopa–foscarbidopa for treating advanced Parkinson's with motor symptoms
TA934
29 November 2023
29 November 2023
Decitabine–cedazuridine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable (terminated appraisal)
TA932
23 November 2023
23 November 2023
Percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis
IPG777
22 November 2023
22 November 2023
Zanubrutinib for treating chronic lymphocytic leukaemia
TA931
22 November 2023
22 November 2023
Biodegradable subacromial spacer insertion for rotator cuff tears
IPG775
15 November 2023
15 November 2023
Extracorporeal carbon dioxide removal for acute respiratory failure
IPG776
15 November 2023
15 November 2023
Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more treatments
TA930
15 November 2023
15 November 2023
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
TA929
1 November 2023
1 November 2023
Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine
TA928
1 November 2023
1 November 2023
Ranibizumab for treating diabetic macular oedema
TA274
27 February 2013
26 October 2023
Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions
IPG774
25 October 2023
25 October 2023
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable
TA917
25 October 2023
25 October 2023
Tirzepatide for treating type 2 diabetes
TA924
25 October 2023
25 October 2023
Mirikizumab for treating moderately to severely active ulcerative colitis
TA925
25 October 2023
25 October 2023
Baricitinib for treating severe alopecia areata
TA926
25 October 2023
25 October 2023
Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus (terminated appraisal)
TA923
19 October 2023
19 October 2023
Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia
IPG773
18 October 2023
18 October 2023
Rimegepant for treating migraine
TA919
18 October 2023
18 October 2023
Tofacitinib for treating active ankylosing spondylitis
TA920
18 October 2023
18 October 2023
Ruxolitinib for treating polycythaemia vera
TA921
18 October 2023
18 October 2023
Daridorexant for treating long-term insomnia
TA922
18 October 2023
18 October 2023
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
TA927
17 October 2023
17 October 2023
Bimekizumab for treating axial spondyloarthritis
TA918
11 October 2023
11 October 2023
Pegunigalsidase alfa for treating Fabry disease
TA915
4 October 2023
4 October 2023
Bimekizumab for treating active psoriatic arthritis
TA916
4 October 2023
4 October 2023
Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatment
IPG772
21 September 2023
21 September 2023
Birch bark extract for treating epidermolysis bullosa
HST28
20 September 2023
20 September 2023
Previous page
1
Current page
2
3
4
…
33
Page
2
of
33
Next page
Results per page
10
25
50
All
Back to top